Vyome (HIND) Performance Overview
Vyome (HIND) closed the trading session on Friday, 23 November 2026, at USD 1.78 per share, reflecting a decline of ‑2.17 % over the 24‑hour period ending at 06:37 PM Central Europe.
- Current share price: USD 1.78
- Current supply of shares: 7 million
- Market capitalization: USD 12.9 million
- 24‑hour trading volume: USD 18.9 thousand
- 24‑hour volume compared with the previous month end: ‑10.45 %
The simple moving average (SMA) for the last 200 days is USD 2.29. Historical price extremes over the past 52 weeks:
- Highest price: USD 6.56 on 11 March 2025
- Lowest price: USD 1.75 on 22 October 2026
Comparative Performance of Related Stocks
| Symbol | 24‑hour movement | Current price | Market capitalization |
|---|---|---|---|
| Bionano Genomics (BNGO) | Flat (0 %) | USD 1.12 | USD 14.7 million |
| Tscan Therapeutics (TCRX) | Flat (0 %) | USD 0.21 | USD 15.2 million |
| Bimergen Energy (BESS) | Down (‑3.5 %) | USD 1.89 | USD 14.2 million |
| Biocardia (BCDA) | Down (‑5.1 %) | USD 0.92 | USD 14.9 million |
| Reborn Coffee (REBN) | Down (‑1.7 %) | USD 1.70 | USD 14.9 million |
Bimergen Energy (BESS) Earnings Update
Bimergen Energy reported a quarterly profit decline of approximately 25 % versus the prior period. Management cited increased operating costs and a modest demand slowdown as primary factors. The company reiterated its long‑term growth strategy, underscored ongoing research and development investments, and confirmed that cash flow remains robust. No material changes to earnings guidance or corporate actions were announced. Share price reaction was muted, indicating market focus on future earnings outlook.
Reborn Coffee (REBN) Strategic Agreement
On 11 October 2026, Reborn Coffee filed a report announcing a Master Product Supply Agreement with Visvita Corporation. Key terms:
- Effective period: two years, automatically renewable
- Products covered: aloe‑vera beverages and other specified items
- Pricing, quantities, delivery dates, and payment terms to be determined by purchase orders
- First‑year volume target: approximately USD 30 million
- Initial order: USD 2 million
- Supply non‑exclusive; Visvita may source elsewhere
- Shipping terms: CIF; Reborn Coffee responsible for freight and insurance from South Korea to U.S. warehouse; Visvita handles regulatory compliance
The filing included the full agreement text and a press release summarizing these terms.
Company Profile – Vyome (ReShape Lifesciences, Inc.)
ReShape Lifesciences, Inc. operates in the healthcare sector, providing medical devices designed for weight‑loss management and treatment of obesity and metabolic diseases on a global scale. The company focuses on delivering innovative solutions that address metabolic health challenges.
